Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Atorvastatin on Microvascular Endothelial Function and Raynaud in Early Diffuse Systemic Sclerosis

NCT02370784 is registered in ClinicalTrials.gov with Robyn T. Domsic, MD, MPH as lead sponsor.

NCT NCT02370784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02370784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Atorvastatin on Microvascular Endothelial Function and Raynaud in Early Diffuse Systemic Sclerosis
Lead sponsor
Robyn T. Domsic, MD, MPH
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2015
Completion date
December 15, 2019
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

scleroderma